Diagnosis and Management of Pneumonia in the Emergency Department

Infectious Disease Clinics of North America

Volumn 22, Issue 1, 2008, Pages 53-72

  Moran, Gregory J ^a,b,c   Talan, David A ^a,b,c   Abrahamian, Fredrick M ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Olive View UCLA   (United States)

^c OLIVE VIEW UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; AMINOGLYCOSIDE PLUS MACROLIDE; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; ATOVAQUONE; AZITHROMYCIN; BETA LACTAM; CEFDINIR; CEFEPIME; CEFOTAXIME; CEFPODOXIME; CEFTRIAXONE; CEPHALOSPORIN; CLINDAMYCIN; COTRIMOXAZOLE; DAPTOMYCIN; DOXYCYCLINE; ERTAPENEM; LEVOFLOXACIN; LINEZOLID; MOXIFLOXACIN; OSELTAMIVIR; PENTAMIDINE; PIPERACILLIN PLUS TAZOBACTAM; PRIMAQUINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIMANTADINE; SULTAMICILLIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANCOMYCIN;

ANTIMICROBIAL THERAPY; BLOOD CULTURE; CAUSE OF DEATH; CLINICAL PRACTICE; CLINICAL TRIAL; COMMUNITY ACQUIRED PNEUMONIA; COUGHING; DECISION MAKING; DIAGNOSTIC PROCEDURE; DRUG ABSORPTION; DRUG SUBSTITUTION; EMERGENCY CARE; EMERGENCY WARD; GRAM STAINING; HEALTH STATUS; HOSPITAL ADMISSION; HUMAN; INFECTION CONTROL; LABORATORY DIAGNOSIS; MEDICAL DECISION MAKING; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; NONHUMAN; OUTPATIENT DEPARTMENT; PATIENT CARE; PLEURA EFFUSION; PNEUMONIA; REVIEW; SOFT TISSUE INFECTION; SPUTUM CULTURE; SPUTUM CYTODIAGNOSIS; THORAX RADIOGRAPHY;

ANTI-INFECTIVE AGENTS; DECISION MAKING; EMERGENCY MEDICINE; HOSPITALIZATION; HUMANS; PNEUMONIA; SPUTUM;

EID: 39449106621     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idc.2007.10.003     Document Type: Review

References (71)

1. Mandell L.A., Wunderink R.G., Anzueto A., et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 44 Suppl 2 (2007) S27-S72
2. Metley J.P., Stafford R.S., and Singer D.E. National trends in the use of antibiotics by primary care physicians for adult patients with cough. Arch Intern Med 158 16 (1998) 1813-1818
3. Mower W.R., Sachs C., Nicklin E.L., et al. Effect of routine emergency department triage pulse oximetry screening on medical management. Chest 108 5 (1995) 1297-1302
4. Metlay J.P., Kapoor W.N., and Fine M.J. Does this patient have community-acquired pneumonia?. JAMA 278 17 (1997) 1440-1445
5. Singal B.M., Hedges J.R., and Radack K.L. Decision rules and clinical prediction of pneumonia: evaluation of low yield criteria. Ann Emerg Med 18 1 (1989) 13-20
6. Heckerling P.S., Tape T.G., Wigton R.S., et al. Clinical prediction rule for pulmonary infiltrates. Ann Intern Med 113 9 (1990) 664-670
7. Emerman C.L., Dawson N., Speroff T., et al. Comparison of physician judgment and decision aids for ordering chest radiographs for pneumonia in outpatients. Ann Emerg Med 20 11 (1991) 1215-1219
8. Syrjala H., Broas M., Suramo I., et al. High-resolution computed tomography for the diagnosis of community-acquired pneumonia. Clin Infect Dis 27 2 (1998) 358-363
9. Sherman S., Skoney J.A., and Ravikrishnan K.P. Routine chest radiographs in exacerbations of chronic obstructive pulmonary disease: diagnostic value. Arch Intern Med 149 11 (1989) 2493-2496
10. Bramson R.T., Meyer T.L., Silbiger M.L., et al. The futility of the chest radiograph in the febrile infant without respiratory symptoms. Pediatrics 92 4 (1993) 524-526
11. Baraff L.J. Management of fever without source in infants and children. Ann Emerg Med 36 6 (2000) 602-614
12. Bachur R., Perry H., and Harper M.B. Occult pneumonias: empiric chest radiographs in febrile children with leukocytosis. Ann Emerg Med 33 2 (1999) 166-173
13. Green S.M., and Rothrock S.G. Evaluation styles for well-appearing febrile children: are you a "risk-minimizer" or a "test-minimizer"?. Ann Emerg Med 33 2 (1999) 211-214
14. Melbye H., Berdal B.P., Straume B., et al. Pneumonia: a clinical or radiographic diagnosis?. Scand J Infect Dis 24 5 (1992) 647-655
15. Hall F.M., and Simon M. Occult pneumonia associated with dehydration: myth or reality?. Am J Radiology 148 5 (1987) 853-854
16. Caldwell A., Glauser F.L., Smith W.R., et al. The effects of dehydration on the radiologic and pathologic appearance of experimental canine segmental pneumonia. Am Rev Respir Dis 112 5 (1975) 651-656
17. Centers for Disease COntrol and Prevention. General and laboratory considerations: rapid HIV tests currently available in the United States. Available at: http://www.cdc.gov/hiv/topics/testing/resources/factsheets/rt-lab.htm. Accessed October 1, 2007.
18. Blatt S.P., Lucey C.R., Butzin C.A., et al. Total lymphocyte count as a predictor of absolute CD4+ count and CD4+ percentage in HIV-infected persons. JAMA 269 5 (1993) 622-626
19. Fang G.D., Fine M., Orloff J., et al. New and emerging etiologies for community-acquired pneumonia with implications for therapy: a prospective multicenter study of 359 cases. Medicine 69 5 (1990) 307-316
20. Centers for Disease Control and Prevention. Severe methicillin-resistant Staphylococcus aureus community-acquired pneumonia associated with influenza: Louisiana and Georgia, December 2006-January 2007. MMWR Morb Mortal Wkly Rep 56 14 (2007) 325-329
21. Moran G.J., and Abrahamian F.M. Blood cultures for pneumonia: can we hit the target without a shotgun?. Ann Emerg Med 46 5 (2005) 407-408
22. Walls R.M., and Resnick J. The Joint Commission on Accreditation of Healthcare Organizations and Center for Medicare and Medicaid Services community-acquired pneumonia initiative: what went wrong?. Ann Emerg Med 46 5 (2005) 409-411
23. Kennedy M., Bates D.W., Wright S.B., et al. Do emergency department blood cultures change practice in patients with pneumonia?. Ann Emerg Med 46 5 (2005) 393-400
24. Chalasani N.P., Valdecanas M.A., Gopal A.K., et al. Clinical utility of blood cultures in adult patients with community-acquired pneumonia without defined underlying risks. Chest 108 4 (1995) 932-936
25. Corbo J., Friedman B., Bijur P., et al. Limited usefulness of initial blood cultures in community acquired pneumonia. Emerg Med J 21 4 (2004) 446-448
26. Campbell S.G., Marrie T.J., Anstey R., et al. The contribution of blood cultures to the clinical management of adult patients admitted to the hospital with community-acquired pneumonia: a prospective observational study. Chest 123 4 (2003) 1142-1150
27. Frazee B.W., Salz T.O., Lambert L., et al. Fatal community-associated methicillin-resistant Staphylococcus aureus pneumonia in an immunocompetent young adult. Ann Emerg Med 46 5 (2005) 401-404
28. Hageman J.C., Uyeki T.M., Francis J.S., et al. Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season. Emerg Infect Dis 12 6 (2006) 894-899
29. Mandell L.A., Marrie T.J., Grossman R.F., et al. Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Community-Acquired Pneumonia Working Group. Clin Infect Dis 31 2 (2000) 383-421
30. Agency for Healthcare Research and Quality. National quality measures clearinghouse: pneumonia. Available at: http://www.qualitymeasures.ahrq.gov/summary/summary.aspx?doc_id=9499. Accessed October 1, 2007.
31. McMahon Jr. L.F., Wolfe R.A., and Tedeschi P.J. Variation in hospital admission among small areas: a comparison of Maine and Michigan. Med Care 27 6 (1989) 623-631
32. Fine M.J., Smith D.N., and Singer D.E. Hospitalization decision in patients with community-acquired pneumonia: a prospective cohort study. Am J Med 89 6 (1990) 713-721
33. Black E.R., Mushlin A.I., Griner P.F., et al. Predicting the need for hospitalization of ambulatory patients with pneumonia. J Gen Intern Med 6 5 (1991) 394-400
34. Fine M.J., Auble T.E., Yealy D.M., et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 336 4 (1997) 243-250
35. Marrie T.J., Lau C.Y., Wheeler S.L., et al. A controlled trial of a critical pathway for treatment of community-acquired pneumonia. JAMA 283 6 (2000) 749-755
36. Carratala J., Fernandez-Sabe N., Ortega L., et al. Outpatient care compared with hospitalization for community-acquired pneumonia: a randomized trial in low-risk patients. Ann Intern Med 142 3 (2005) 165-172
37. Yealy D.M., Auble T.E., Stone R.A., et al. Effect of increasing the intensity of implementing pneumonia guidelines: a randomized, controlled trial. Ann Intern Med 143 12 (2005) 881-894
38. Lim W.S., van der Eerden M.M., Liang R., et al. Defining community-acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 58 5 (2003) 377-382
39. Aujesky D., Auble T.E., Yealy D.M., et al. Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia. Am J Med 118 4 (2005) 384-392
40. Masur H. Prevention and treatment of Pneumocystis pneumonia. N Engl J Med 327 26 (1992) 1853-1860
41. Ewig S., de Roux A., Bauer T., et al. Validation of predictive rules and indices of severity for community-acquired pneumonia. Thorax 59 5 (2004) 421-427
42. Leroy O., Santre C., Beuscart C., et al. A five-year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit. Intensive Care Med 21 1 (1995) 24-31
43. Angus D.C., Marrie T.J., Obrosky D.S., et al. Severe community-acquired pneumonia: use of intensive care services and evaluation of American and British Thoracic Society Diagnostic criteria. Am J Respir Crit Care Med 166 5 (2002) 717-723
44. Committee on the Future of Emergency Care in the United States Health System. Hospital-based emergency care: at the breaking point (2006), National Academies Press, Washington, DC
45. Rothman R.E., Irvin C.B., Moran G.J., et al. Respiratory hygiene in the emergency department. Ann Emerg Med 48 5 (2006) 570-582
46. Sokolove P.E., Mackey D., Wiles J., et al. Exposure of emergency department personnel to tuberculosis: PPD testing during an epidemic in the community. Ann Emerg Med 24 3 (1994) 418-421
47. Moran G.J., McCabe F., Morgan M.T., et al. Delayed recognition and infection control for tuberculosis patients in the emergency department. Ann Emerg Med 26 3 (1995) 290-295
48. Baker D.W., Stevens C.D., and Brook R.H. Regular source of ambulatory care and medical care utilization by patients presenting to a public hospital emergency department. JAMA 271 24 (1994) 1909-1912
49. Moran G.J., Fuchs M.A., Jarvis W.R., et al. Tuberculosis infection-control practices in United States emergency departments. Ann Emerg Med 26 3 (1995) 283-289
50. Centers for Disease Control and Prevention. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities, 1994. MMWR Recomm Rep 43 RR-13 (1994) 1-132
51. El-Solh A., Mylotte J., Sherif S., et al. Validity of a decision tree for predicting active pulmonary tuberculosis. Am J Respir Crit Care Med 155 5 (1997) 1711-1716
52. Tattevin P., Casalino E., Fleury L., et al. The validity of medical history, classic symptoms, and chest radiographs in predicting pulmonary tuberculosis. Chest 115 5 (1999) 1248-1253
53. Wisnivesky J.P., Henschke C., Balentine J., et al. Prospective validation of a prediction model for isolating inpatients with suspected pulmonary tuberculosis. Arch Intern Med 165 4 (2005) 453-457
54. Wisnivesky J.P., Serebrisky D., Moor C., et al. Validity of clinical prediction rules for isolating inpatients with suspected tuberculosis: a systematic review. J Gen Intern Med 20 10 (2005) 947-952
55. Nguyen H.B., Rivers E.P., Abrahamian F.M., et al. Severe sepsis and septic shock: review of the literature and emergency department management guidelines. Ann Emerg Med 48 1 (2006) 28-54
56. Meehan T.P., Fine M.J., Krumholz H.M., et al. Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA 278 23 (1997) 2080-2084
57. Houck P.M., Bratzler D.W., Nsa W., et al. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med 164 6 (2004) 637-644
58. Pines J.M., Morton M.F., Datner E.M., et al. Systematic delays in antibiotic administration in the emergency department for adult patients admitted with pneumonia. Acad Emerg Med 13 9 (2006) 939-945
59. Fee C., and Weber E.J. Identification of 90% of patients ultimately diagnosed with community-acquired pneumonia within four hours of emergency department arrival may not be feasible. Ann Emerg Med 49 5 (2007) 553-559
60. Pines J.M., Hollander J.E., Lee H., et al. Emergency department operational changes in response to pay-for-performance and antibiotic timing in pneumonia. Acad Emerg Med 14 6 (2007) 545-548
61. Kelen G.D., and Rothman R.E. Community pneumonia practice standard mandates: can't see the forest for the trees. Acad Emerg Med 13 9 (2006) 986-988
62. Battleman D.S., Callahan M., and Thaler H.T. Rapid antibiotic delivery and appropriate antibiotic selection reduce length of hospital stay of patients with community-acquired pneumonia. Arch Intern Med 162 6 (2002) 682-688
63. Moran G.J., Krishnadasan A., Gorwitz R.J., et al., for The EMERGEncy ID NET Study Group. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 355 7 (2006) 666-674
64. Mohr J.F., and Murray B.E. Point: vancomycin is not obsolete for the treatment of infection caused by methicillin-resistant Staphylococcus aureus. Clin Infect Dis 44 12 (2007) 1536-1542
65. Deresinski S. Counterpoint: vancomycin and Staphylococcus aureus. An antibiotic enters obsolescence. Clin Infect Dis 44 12 (2007) 1543-1548
66. Wunderink R.G., Rello J., Cammarate S.K., et al. Linezolid vs. vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Chest 124 5 (2003) 1789-1797
67. Kollef M.H., Shorr A., Tabak Y.P., et al. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 128 6 (2005) 3854-3862
68. American Thoracic Society. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171 4 (2005) 388-416
69. Gubareva L.V., Kaiser L., and Hayden F.G. Influenza virus neuraminidase inhibitors. Lancet 355 9206 (2000) 827-835
70. Centers for Disease Control and Prevention. High levels of adamantane resistance among influenza A (H3N2) viruses and interim guidelines for use of antiviral agents: United States, 2005-06 influenza season. MMWR Morb Mortal Wkly Rep 55 02 (2006) 44-46
71. Moran G.J. Approaches to treatment of community-acquired pneumonia in the emergency department and the appropriate role of fluoroquinolones. J Emerg Med 30 4 (2006) 377-387